tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NRIX Stock Latest News

Nurix Therapeutics management to meet with Oppenheimer
The FlyNurix Therapeutics management to meet with Oppenheimer
7d ago
NRIX
Nurix Therapeutics To Participate in Upcoming ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit
PremiumPress Releases
Nurix Therapeutics To Participate in Upcoming ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit
14d ago
NRIX
Nurix Therapeutics transferred with an Outperform at Baird
PremiumThe Fly
Nurix Therapeutics transferred with an Outperform at Baird
15d ago
NRIX
Nurix Therapeutics Showcases Breakthrough BTK Degraders
PremiumCompany Announcements
Nurix Therapeutics Showcases Breakthrough BTK Degraders
15d ago
8K
NRIX
Nurix Therapeutics price target raised to $30 from $27 at Oppenheimer
PremiumThe Fly
Nurix Therapeutics price target raised to $30 from $27 at Oppenheimer
16d ago
SNY
NRIX
Nurix Therapeutics to Participate in Upcoming Investor Conferences
PremiumPress ReleasesNurix Therapeutics to Participate in Upcoming Investor Conferences
22d ago
NRIX
Nurix Therapeutics price target raised to $27 from $25 at Oppenheimer
Premium
The Fly
Nurix Therapeutics price target raised to $27 from $25 at Oppenheimer
1M ago
NRIX
McDonald’s downgraded, PayPal upgraded: Wall Street’s top analyst calls
Premium
The Fly
McDonald’s downgraded, PayPal upgraded: Wall Street’s top analyst calls
2M ago
GO
ECL
Nurix Therapeutics initiated with a Buy at Truist
PremiumThe Fly
Nurix Therapeutics initiated with a Buy at Truist
2M ago
NRIX
Nurix Therapeutics price target raised to $34 from $31 at JPMorgan
PremiumThe Fly
Nurix Therapeutics price target raised to $34 from $31 at JPMorgan
2M ago
NRIX
Nurix Therapeutics price target raised to $31 from $20 at Barclays
PremiumThe Fly
Nurix Therapeutics price target raised to $31 from $20 at Barclays
2M ago
NRIX
Nurix Therapeutics price target raised to $15 from $14 at Morgan Stanley
PremiumThe Fly
Nurix Therapeutics price target raised to $15 from $14 at Morgan Stanley
2M ago
NRIX
Investor interest in Nurix Therapeutics keeps climbing, says Oppenheimer
PremiumThe FlyInvestor interest in Nurix Therapeutics keeps climbing, says Oppenheimer
2M ago
NRIX
Nurix Therapeutics price target raised to $27 from $26 at RBC Capital
Premium
The Fly
Nurix Therapeutics price target raised to $27 from $26 at RBC Capital
2M ago
NRIX
Nurix Therapeutics price target lowered to $29 from $31 at Needham
Premium
The Fly
Nurix Therapeutics price target lowered to $29 from $31 at Needham
2M ago
NRIX
Nurix Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
PremiumPress Releases
Nurix Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
2M ago
NRIX
Nurix Therapeutics reports Q2 EPS (71c), consensus (63c)
PremiumThe Fly
Nurix Therapeutics reports Q2 EPS (71c), consensus (63c)
2M ago
NRIX
Nurix Therapeutics to Participate in the UBS Virtual Targeted Protein Degradation (TPD) Day
PremiumPress Releases
Nurix Therapeutics to Participate in the UBS Virtual Targeted Protein Degradation (TPD) Day
2M ago
NRIX
Is NRIX a Buy, Before Earnings?
PremiumPre-Earnings
Is NRIX a Buy, Before Earnings?
2M ago
NRIX
Nurix Therapeutics price target raised to $26 from $23 at RBC Capital
PremiumThe FlyNurix Therapeutics price target raised to $26 from $23 at RBC Capital
3M ago
NRIX
Nurix Therapeutics price target raised to $26 from $19 at H.C. Wainwright
Premium
The Fly
Nurix Therapeutics price target raised to $26 from $19 at H.C. Wainwright
3M ago
NRIX
Nurix Therapeutics management to meet with Piper Sandler
Premium
The Fly
Nurix Therapeutics management to meet with Piper Sandler
3M ago
NRIX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >